Yan Lin Ping-Yu Liu
10.3389/fphar.2022.994865
Front Pharmacol
2022 Sep 13;13:994865.
ctcea grade 3 case report severe rash/desquamation sorafenib unresectable hepatocellular carcinoma
CC BY
https://pubmed.ncbi.nlm.nih.gov/36176447/
Case Reports
PMC9514041
36176447
Case Report: Severe rash/desquamation induced by sorafenib in an uHCC patient and its clinical management
2022